Unit of Molecular Psychiatry, Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
PLoS One. 2010 Aug 18;5(8):e12254. doi: 10.1371/journal.pone.0012254.
The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys)function, a linkage scan in large pedigrees identified AHI1 as a positional candidate for schizophrenia. To further investigate the contribution of AHI1 to the susceptibility of schizophrenia, we evaluated the effect of AHI1 variation on the vulnerability to psychosis in two samples from Spain and Germany.
METHODOLOGY/PRINCIPAL FINDINGS: 29 single-nucleotide polymorphisms (SNPs) located in a genomic region including the AHI1 gene were genotyped in two samples from Spain (280 patients with psychotic disorders; 348 controls) and Germany (247 patients with schizophrenic disorders; 360 controls). Allelic, genotypic and haplotype frequencies were compared between cases and controls in both samples separately, as well as in the combined sample. The effect of genotype on several psychopathological measures (BPRS, KGV, PANSS) assessed in a Spanish subsample was also evaluated. We found several significant associations in the Spanish sample. Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031, respectively) and allelic frequencies (p = 0.001 in both cases). Moreover, several other risk and protective haplotypes were detected (0.006<p<0.036). Joint analysis also supported the association of rs7750586 and rs911507 with the risk for schizophrenia. The analysis of clinical measures also revealed an effect on symptom severity (minimum P value = 0.0037).
CONCLUSIONS/SIGNIFICANCE: Our data support, in agreement with previous reports, an effect of AHI1 variation on the susceptibility to schizophrenia in central and southern European populations.
Abelson 辅助整合因子 1(AHI1)基因对于人类小脑和大脑皮层的发育都是必需的。虽然 AHI1 在人类谱系中的快速进化表明其在认知(功能)障碍中起作用,但在大型家系中的连锁扫描将 AHI1 确定为精神分裂症的候选基因。为了进一步研究 AHI1 对精神分裂症易感性的贡献,我们评估了 AHI1 变异对来自西班牙和德国的两个样本中精神疾病易感性的影响。
方法/主要发现:在来自西班牙的两个样本(280 名有精神病障碍的患者;348 名对照)和德国的两个样本(247 名患有精神分裂症的患者;360 名对照)中,对位于包含 AHI1 基因的基因组区域中的 29 个单核苷酸多态性(SNP)进行了基因分型。在两个样本中分别比较了病例组和对照组之间的等位基因、基因型和单倍型频率,以及合并样本中的频率。还评估了西班牙亚组中几个心理病理测量(BPRS、KGV、PANSS)的基因型对基因型的影响。我们在西班牙样本中发现了几个显著的关联。特别是,位于 AHI1 编码区上游的 rs7750586 和 rs911507 与基因型分析中的精神分裂症相关(p = 0.0033 和 0.031)和等位基因频率(两者均为 p = 0.001)。此外,还检测到了其他几个风险和保护单倍型(0.006<p<0.036)。联合分析也支持 rs7750586 和 rs911507 与精神分裂症风险的关联。临床测量的分析也显示出对症状严重程度的影响(最小 P 值 = 0.0037)。
我们的数据支持,与先前的报告一致,AHI1 变异对中欧和南欧人群精神分裂症易感性的影响。